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Refractory ventricular fibrillation (VF) cardiac arrest is a chal-
lenge because of the scarcity of drugs and poor survival.
Extracorporeal cardiopulmonary resuscitation (eCPR) and
percutaneous stellate ganglion block (PSGB) can improve
outcome by supporting circulation and by blocking the sym-
pathetic innervation of the heart, respectively. However, little
is known about their combination.
A 54-year-old woman suffered a cardiac arrest witnessed
by rescuers of the emergency medical system (EMS) (Panel A).
At hospital arrival, she was still in VF after 6 shocks and stand-
ard therapy. After 45 min of eCPR, VF was still present
despite other 10 shocks. So, through a 22G needle 200 mg of
Lidocaine were injected using the anatomical-based anterior
approach at the level of C6. Anisocoria appeared in 2 min
(Panel B), and the subsequent shock restored sinus rhythm
stably. A primary coronary intervention on the proximal left
anterior descendant artery was performed after which, 1 h
after the PSGB, further six relapses of VF occurred despite
the infusion of Lidocaine. Since anisocoria was diminishing,
PSGB was repeated, using 100 mg of Lidocaine and 50 mg of
Bupivacaine. Anisocoria reappeared and the subsequent
shock was effective. Neither other arrhythmias nor complica-
tions related to PSGB occurred.
The full-length version of this report can be viewed at: https://
www.escardio.org/Education/E-Learning/Clinical-cases/
Electrophysiology.
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